1. Home
  2. IBEX vs PBYI Comparison

IBEX vs PBYI Comparison

Compare IBEX & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IBEX Limited

IBEX

IBEX Limited

N/A

Current Price

$37.38

Market Cap

448.0M

Sector

Technology

ML Signal

N/A

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

N/A

Current Price

$9.23

Market Cap

413.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IBEX
PBYI
Founded
2017
2010
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
448.0M
413.3M
IPO Year
2017
2011

Fundamental Metrics

Financial Performance
Metric
IBEX
PBYI
Price
$37.38
$9.23
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$35.00
N/A
AVG Volume (30 Days)
92.5K
296.2K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
28.26
N/A
EPS
2.54
0.08
Revenue
$558,273,000.00
$27,685,000.00
Revenue This Year
$14.13
N/A
Revenue Next Year
$5.68
N/A
P/E Ratio
$14.42
$114.50
Revenue Growth
9.77
N/A
52 Week Low
$25.94
$4.30
52 Week High
$42.99
$9.51

Technical Indicators

Market Signals
Indicator
IBEX
PBYI
Relative Strength Index (RSI) 61.29 61.69
Support Level $36.51 $7.44
Resistance Level $39.81 $9.45
Average True Range (ATR) 1.13 0.36
MACD -0.00 0.02
Stochastic Oscillator 91.83 78.64

Price Performance

Historical Comparison
IBEX
PBYI

About IBEX IBEX Limited

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: